Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

_{Oxford Clinical Trials Research Unit}

ABOUT US THEMES PORTFOLIO NEWS TRAINING INTERVENTIONS OUR TEAM METHODOLOGY PATIENT AND PUBLIC INVOLVEMENT

TRIALS

PPI

JOIN OUR TEAM

Our news

WHiTE 15: INITIATE Opens to Recruitment!

14 August 2024
OCTRU 2023 CTU Award Winners Announced!

31 July 2024
SITU announces a trio of new trials

18 June 2024
ODD SOCKS Opens to Recruitment

30 May 2024
WHITE-13 DECI Trial now open to recruitment

28 May 2024

More news

Our training sessions

Add to my calendar

OCTRU Summer Meeting Workshop: Use of media/videos in patient recruitment/dissemination

Tuesday, 15 October 2024, 9am to 11am @ Nuffield Orthopaedic Centre, ND08
Add to my calendar

OCTRU New Starter Training *ONLINE*

Tuesday, 15 October 2024, 10am to 11.30am
Add to my calendar

Trials Expertise Session: Communication skills in Clinical Trials for Trial Managers

Tuesday, 22 October 2024, 1pm to 2pm @ Botnar Research Centre, G54
Add to my calendar

OCTRU Training Bite: SWATs

Wednesday, 23 October 2024, 9.30am to 10.30am @ Botnar G54

More training

Our recent publications

Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project

Black J. et al, (2024), Trials
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Mukherjee S. et al, (2024), Eur j cancer, 209
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy

Hamdy FC. et al, (2024), European journal of nuclear medicine and molecular imaging
Early versus delayed weight-bearing following operatively treated ankle fracture (WAX): a non-inferiority, multicentre, randomised controlled trial.

Bretherton CP. et al, (2024), Lancet, 403, 2787 - 2797
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).

Spiliopoulou P. et al, (2024), J exp clin cancer res, 43
Cost-effectiveness analysis of a pragmatic randomized trial evaluating surgical reconstruction versus rehabilitation in patients with long-standing anterior cruciate ligament injury.

Leal J. et al, (2024), Bone joint j, 106-B, 38 - 45

Collaborate with us!

We are open for collaborations and welcome your requests at any point.

Let's chat

NIHR CTU SUPPORT

This unit receives National Institute for Health Research CTU Support Funding.
This funding has been awarded to support the unit in developing and supporting NIHR trials.